Actualités

Consultez les derniers articles autour de la maladie de Willebrand

Dernière mise à jour : Mardi 19 mars 2024

Diagnosis and treatment challenges in lower resource countries: State‐of‐the‐art

In the last several decades, the bleeding disorders community has seen an unprecedented evolution of novel therapies for treating inherited disorders. These therapies have included recombinant clotting...
Lire la suite

Haemophilia 2024; AOP: 10.1111/hae.14956
Johnny Mahlangu et al.

Von Willebrand Disease and Pregnancy: Management Protocol From Labor to the Postpartum Period.

Von Willebrand disease (VWD) is a hemostatic disorder characterized by a quantitative or qualitative deficiency of the Von Willebrand factor (VWF). It affects males and females equally. This pathology...
Lire la suite

Cureus 2024 Feb; 16(2): e53465
Muoz Vargas Brandon Alejandro et al.

Real-world evidence for coverage determination of treatments for rare diseases

In order for patients to gain access to new pharmaceuticals, manufacturers must successfully navigate two critical steps. First, they need to obtain marketing approval (i.e., approval to market) from a...
Lire la suite

Orphanet Journal of Rare Diseases 2024; 19(1): 47
Dayer Victoria W. et al.

Bleeding Disorder of Unknown Cause: A Diagnosis of Exclusion.

Patients with an unexplained mild to moderate bleeding tendency are diagnosed with bleeding disorder of unknown cause (BDUC), a classification reached after ruling out other mild to moderate bleeding disorders (MBD) including von Willebrand disease (VWD), platelet function defects (PFDs), coagulation factor deficiencies (CFDs), and non-hemostatic causes for bleeding. This review outlines our diagnostic approach to BDUC, a diagnosis of exclusion, drawing...
Lire la suite

Hamostaseologie 2024 Feb
Mehic Dino et al.

Recherche bibliographique

Recherche avancée Besoin d'aide ?

Recherche par revues :
136 articles actuellement disponibles


Découvrez WillebrandXPERTet ses fonctionnalités en quelques instants